163 related articles for article (PubMed ID: 26396545)
1. Time-serial Assessment of Drug Combination Interventions in a Mouse Model of Colorectal Carcinogenesis Using Optical Coherence Tomography.
LeGendre-McGhee S; Rice PS; Wall RA; Sprute KJ; Bommireddy R; Luttman AM; Nagle RB; Abril ER; Farrell K; Hsu CH; Roe DJ; Gerner EW; Ignatenko NA; Barton JK
Cancer Growth Metastasis; 2015; 8(Suppl 1):63-80. PubMed ID: 26396545
[TBL] [Abstract][Full Text] [Related]
2. Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine.
Lawson KR; Ignatenko NA; Piazza GA; Cui H; Gerner EW
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1155-62. PubMed ID: 11097222
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats.
Madka V; Patlolla JMR; Venkatachalam K; Zhang Y; Pathuri G; Stratton N; Lightfoot S; Janakiram NB; Mohammed A; Rao CV
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568816
[TBL] [Abstract][Full Text] [Related]
4. Intermittent Dosing with Sulindac Provides Effective Colorectal Cancer Chemoprevention in the Azoxymethane-Treated Mouse Model.
Chandra S; Nymeyer AC; Rice PF; Gerner EW; Barton JK
Cancer Prev Res (Phila); 2017 Aug; 10(8):459-466. PubMed ID: 28611038
[TBL] [Abstract][Full Text] [Related]
5. Aberrant arachidonic acid metabolism in esophageal adenocarcinogenesis, and the effects of sulindac, nordihydroguaiaretic acid, and alpha-difluoromethylornithine on tumorigenesis in a rat surgical model.
Chen X; Li N; Wang S; Hong J; Fang M; Yousselfson J; Yang P; Newman RA; Lubet RA; Yang CS
Carcinogenesis; 2002 Dec; 23(12):2095-102. PubMed ID: 12507933
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of sulindac-resistant adenomas in familial adenomatous polyposis.
Keller JJ; Offerhaus GJ; Drillenburg P; Caspers E; Musler A; Ristimäki A; Giardiello FM
Clin Cancer Res; 2001 Dec; 7(12):4000-7. PubMed ID: 11751493
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of rat colon tumors by sulindac and sulindac sulfone is independent of K-ras (codon 12) mutation.
de Jong TA; Skinner SA; Malcontenti-Wilson C; Vogiagis D; Bailey M; van Driel IR; O'Brien PE
Am J Physiol Gastrointest Liver Physiol; 2000 Feb; 278(2):G266-72. PubMed ID: 10666051
[TBL] [Abstract][Full Text] [Related]
8. Preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer model.
Nicastro HL; Grubbs CJ; Margaret Juliana M; Bode AM; Kim MS; Lu Y; You M; Milne GL; Boring D; Steele VE; Lubet RA
Cancer Prev Res (Phila); 2014 Feb; 7(2):246-54. PubMed ID: 24346344
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
Rao CV; Rivenson A; Simi B; Zang E; Kelloff G; Steele V; Reddy BS
Cancer Res; 1995 Apr; 55(7):1464-72. PubMed ID: 7882354
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
[TBL] [Abstract][Full Text] [Related]
11. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
[TBL] [Abstract][Full Text] [Related]
12. Sulindac sulfone inhibits K-ras-dependent cyclooxygenase-2 expression in human colon cancer cells.
Taylor MT; Lawson KR; Ignatenko NA; Marek SE; Stringer DE; Skovan BA; Gerner EW
Cancer Res; 2000 Dec; 60(23):6607-10. PubMed ID: 11118042
[TBL] [Abstract][Full Text] [Related]
13. Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis.
Singh J; Kulkarni N; Kelloff G; Reddy BS
Carcinogenesis; 1994 Jul; 15(7):1317-23. PubMed ID: 8033306
[TBL] [Abstract][Full Text] [Related]
14. The chemopreventive agent alpha-difluoromethylornithine blocks Ki-ras-dependent tumor formation and specific gene expression in Caco-2 cells.
Ignatenko NA; Zhang H; Watts GS; Skovan BA; Stringer DE; Gerner EW
Mol Carcinog; 2004 Apr; 39(4):221-33. PubMed ID: 15057874
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mouse bladder tumor proliferation by alpha difluoromethylornithine and interferon in vitro and in vivo.
Bahnson RR; Ratliff TL
J Urol; 1988 Jun; 139(6):1367-71. PubMed ID: 3131549
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors.
Richter M; Weiss M; Weinberger I; Fürstenberger G; Marian B
Carcinogenesis; 2001 Jan; 22(1):17-25. PubMed ID: 11159736
[TBL] [Abstract][Full Text] [Related]
17. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
Meyskens FL; Gerner EW
Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
[TBL] [Abstract][Full Text] [Related]
18. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.
Fink SP; Dawson DM; Zhang Y; Kresak A; Lawrence EG; Yang P; Chen Y; Barnholtz-Sloan JS; Willis JE; Kopelovich L; Markowitz SD
Carcinogenesis; 2015 Feb; 36(2):291-8. PubMed ID: 25503930
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive imaging of carcinogen-induced early neoplasia using ultrahigh-resolution optical coherence tomography.
Cobb MJ; Chen Y; Bailey SL; Kemp CJ; Li X
Cancer Biomark; 2006; 2(3-4):163-73. PubMed ID: 17192069
[TBL] [Abstract][Full Text] [Related]
20. In vivo molecular imaging of colorectal cancer using quantum dots targeted to vascular endothelial growth factor receptor 2 and optical coherence tomography/laser-induced fluorescence dual-modality imaging.
Carbary-Ganz JL; Welge WA; Barton JK; Utzinger U
J Biomed Opt; 2015; 20(9):096015. PubMed ID: 26397238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
